Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jul 21, 2016
EDEN PRAIRIE, Minn., July 21, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) ("Sunshine Heart" or the "Company"), today announced that it has entered into a definitive agreement with a single investor for an offering of shares of convertible preferred stock with gross proceeds of $3,46...

Read More

Posted on Jul 11, 2016
EDEN PRAIRIE, Minn., July 11, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions. After months of collecting data and r...

Read More

Posted on Jun 24, 2016
EDEN PRAIRIE, Minn., June 24, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on June 22, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved six equity awards under Sunshine Heart's New-Hire Equ...

Read More

Events & Presentations